Pharma channel feed

Pfiz­er wants to reel back con­tri­bu­tions to Hyde-Smith af­ter her re­marks about ‘pub­lic hang­ing’ spark con­tro­ver­sy

7 years ago

Roche ties up again with As­cle­tis — this time on a com­mer­cial part­ner­ship for hep B drug

7 years ago

No­var­tis banks on the promise of dig­i­tal ther­a­peu­tics in the man­age­ment of chron­ic dis­or­ders

7 years ago

Clozel hands over a ri­val to PTC’s con­tro­ver­sial steroid de­flaza­cort — now in a piv­otal study for Duchenne MD

7 years ago

So­bi’s $50M bet on a rare dis­ease drug pays off with a quick FDA nod

7 years ago

FDA opts to nail down REMS plan for Sage's land­mark post­par­tum de­pres­sion drug, de­lays fi­nal de­ci­sion

7 years ago

As pow­er shifts hands in Wash­ing­ton, a top an­a­lyst pre­dicts an un­avoid­able war over ris­ing drug prices

7 years ago

FDA works to re­duce dog test­ing in drug de­vel­op­ment

7 years ago

Leo Phar­ma lines up an op­tion to buy Bridge­Bio's Pelle­Pharm and its PhI­II rare skin can­cer drug

7 years ago

While con­tro­ver­sy over Brex­it reach­es full boil, a phar­ma trade group sees the up­side in a draft deal

7 years ago
R&D

Sanofi teams with non-prof­it on a land­mark new drug for sleep­ing sick­ness

7 years ago
R&D
Discovery

Unit­ed Ther­a­peu­tics pays $800M-plus to grab Are­na’s PhI­II PAH drug

7 years ago

Ab­b­Vie en­lists pro­tein degra­da­tion ex­perts at Mis­sion for a new bet on Alzheimer's, Parkin­son's

7 years ago

What's com­ing? Paz­dur, Marks and Wood­cock dis­cuss FDA changes

7 years ago

FDA press­es its cam­paign against rogue re­gen­er­a­tive med play­ers, cites Stem­Genex for il­le­gal sales

7 years ago
Cell/Gene Tx

Cel­gene dou­bles down on Drag­on­fly­'s nat­ur­al killer tech, ex­pand­ing in­to sol­id tu­mors with an in­jec­tion of 'am­pli­fi­ca­tion cap­i­tal'

7 years ago

South Ko­re­an reg­u­la­tor sus­pends Sam­sung Bi­o­Log­ic­s' stock, cit­ing ac­count­ing vi­o­la­tions

7 years ago
R&D

Nestlé ups its bet on Aim­mune’s peanut al­ler­gy drug to $276M as NDA fil­ing looms, ri­val­ry in­ten­si­fies

7 years ago

FDA looks to strength­en ex­pand­ed ac­cess pro­gram

7 years ago

Genen­tech de­tails claims Sanofi part­ner JHL used stolen trade se­crets to de­vel­op ri­val drugs at an 'as­ton­ish­ing pace'

7 years ago
R&D

Ab­b­Vie hatch­es plans for a ma­jor new R&D hub close to its part­ners in Bay Area's buzzy Oys­ter Point

7 years ago
R&D

Drug­mak­ers seek clar­i­ty on guid­ance on use of place­bo and blind­ing in on­col­o­gy tri­als

7 years ago

As­traZeneca chief Pas­cal So­ri­ot her­alds the start of a 'pe­ri­od of sus­tained growth for years to come'

7 years ago

Bris­tol-My­ers lays off the last 63 staffers at Zy­mo­Ge­net­ics, shut­ters Seat­tle op­er­a­tions

7 years ago
First page Previous page 286287288289290291292 Next page Last page
A service from the Financial Times